Novartis AG (NVS)
153.80
+2.68
(+1.78%)
USD |
NYSE |
Oct 26, 16:00
153.80
0.00 (0.00%)
After-Hours: 20:00
Novartis Price to Book Value : 6.777 for Oct. 26, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 6.659 |
| October 22, 2026 | 6.886 |
| October 21, 2026 | 6.783 |
| October 20, 2026 | 6.770 |
| October 19, 2026 | 6.618 |
| October 16, 2026 | 6.637 |
| October 15, 2026 | 6.626 |
| October 14, 2026 | 6.472 |
| October 13, 2026 | 6.275 |
| October 12, 2026 | 6.338 |
| October 09, 2026 | 6.334 |
| October 08, 2026 | 6.306 |
| October 07, 2026 | 6.314 |
| October 06, 2026 | 6.204 |
| October 05, 2026 | 6.210 |
| October 02, 2026 | 6.213 |
| October 01, 2026 | 6.215 |
| September 30, 2026 | 6.282 |
| September 29, 2026 | 6.421 |
| September 28, 2026 | 6.472 |
| September 25, 2026 | 6.410 |
| September 24, 2026 | 6.326 |
| September 23, 2026 | 6.288 |
| September 22, 2026 | 6.226 |
| September 21, 2026 | 6.212 |
| Date | Value |
|---|---|
| September 18, 2026 | 6.185 |
| September 17, 2026 | 6.210 |
| September 16, 2026 | 6.112 |
| September 15, 2026 | 6.108 |
| September 14, 2026 | 6.125 |
| September 11, 2026 | 6.044 |
| September 10, 2026 | 6.058 |
| September 09, 2026 | 6.058 |
| September 08, 2026 | 6.068 |
| September 04, 2026 | 7.050 |
| September 03, 2026 | 7.186 |
| September 02, 2026 | 7.159 |
| September 01, 2026 | 7.106 |
| August 31, 2026 | 6.700 |
| August 28, 2026 | 6.778 |
| August 27, 2026 | 6.815 |
| August 26, 2026 | 6.942 |
| August 25, 2026 | 7.050 |
| August 24, 2026 | 6.963 |
| August 21, 2026 | 7.000 |
| August 20, 2026 | 6.885 |
| August 19, 2026 | 7.064 |
| August 18, 2026 | 6.810 |
| August 17, 2026 | 6.696 |
| August 14, 2026 | 6.648 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Roche Holding AG | -- |
| AstraZeneca PLC | 11.27 |
| GSK Plc | 4.414 |
| Johnson & Johnson | 7.868 |
| Eli Lilly & Co. | 35.55 |
Price to Book Value Related Metrics
| PE Ratio | 23.20 |
| PS Ratio | 5.403 |
| Price to Free Cash Flow | 19.75 |
| Price | 153.80 |
| Earnings Yield | 4.31% |
| Market Cap | 281.55B |
| Operating PE Ratio | 18.26 |
| Normalized PE Ratio | 21.62 |